Adcirca and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Adcirca (tadalafil) and Cyclophosphamide (cyclophosphamide). Common drug interactions include oedema among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Adcirca and Cyclophosphamide. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.
What is Adcirca?
Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
48 people who take Adcirca and Cyclophosphamide together, and have interactions are studied.

What are the common drug interactions of Adcirca and Cyclophosphamide, by gender? *:
female:
- Oedema (fluid collection in tissue)
- White blood cell count decreased
- Anaemia (lack of blood)
- Diarrhoea
- Cytomegalovirus infection
- Oedema peripheral (superficial swelling)
- Hypertension (high blood pressure)
- Urinary tract infection
- Pulmonary vein occlusion (blockage in pulmonary vein)
- Respiratory disorder (respiratory disease)
male:
- Diarrhoea
- Bronchitis bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection)
- Hospitalisation
- Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
- Multi-organ failure (multisystem organ failure)
- Neutropenia (an abnormally low number of neutrophils)
- Pneumonia
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Right ventricular failure (right half of the heart fails to work)
What are the common drug interactions of Adcirca and Cyclophosphamide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
- Gait disturbance
- Memory impairment
- Acute respiratory distress syndrome
- Fall
- Pelvic fracture
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Speech disorder
- Asthma
10-19:
- Cystitis haemorrhagic (blood in the urine and painful voiding)
- Blood urine present
- Suprapubic pain
20-29:
- Nausea (feeling of having an urge to vomit)
- Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
- Blood potassium increased
- Cardiogenic shock (inadequate circulation of blood)
- Drug intolerance (drug sensitivity)
- Multi-organ failure (multisystem organ failure)
- Pneumonia
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Right ventricular failure (right half of the heart fails to work)
30-39:
- Headache (pain in head)
- Anaemia (lack of blood)
- Abdominal pain upper
- Atrial tachycardia (rhythm disturbance that arises in the atria)
- Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Urinary tract infection
- Abdominal distension
- Decreased appetite
40-49:
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
50-59:
- Diarrhoea
- Skin ulcer
- Bronchitis bacterial (inflammation of the mucous membrane in the bronchial tubes due to bacterial infection)
- Liver disorder (liver diseases)
- Nausea (feeling of having an urge to vomit)
- Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
- Hot flush (sudden feelings of heat)
- Interstitial lung disease
- Pain
- Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
60+:
- Oedema (fluid collection in tissue)
- White blood cell count decreased
- Ascites (accumulation of fluid in the abdominal cavity)
- Back pain
- Bacterial infection
- Blood creatinine increased
- Cardiac failure
- Decreased appetite
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Hypokalaemia (low potassium)
What are the existing conditions these people have? *
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 40 people, 83.33%
- Mixed Connective Tissue Disease (an autoimmune disease, in which the body's defence system attacks itself): 14 people, 29.17%
- Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 7 people, 14.58%
- High Blood Pressure: 7 people, 14.58%
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs): 6 people, 12.50%
- Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 6 people, 12.50%
- Pleural Effusion (water on the lungs): 3 people, 6.25%
- Interstitial Lung Disease: 3 people, 6.25%
- Cardiac Failure: 3 people, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Adcirca and Cyclophosphamide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Adcirca (54,957 reports)
- Cyclophosphamide (185,240 reports)
Browse all drug interactions of Adcirca and Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adcirca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adcirca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cyclophosphamide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on tadalafil and cyclophosphamide (the active ingredients of Adcirca and Cyclophosphamide, respectively), and Adcirca and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Streptase cause Nausea And Vomiting? - now
- Drug interactions of Tizanidine Hydrochloride and Vagifem - 5 seconds ago
- Could Lithium Carbonate cause Dehydration? - 5 seconds ago
- Pain and Rebound Effect - 25 seconds ago
- High Blood Pressure and Joint Swelling - 32 seconds ago
- Could Catapres cause Angioneurotic Oedema? - 41 seconds ago
- Could Trelegy Ellipta cause Blood Pressure Abnormal? - a minute ago
- Drug interactions of Tri-Sprintec and Sertraline - a minute ago
- Drug interactions of Comtan and Losartan - a minute ago
- Drug interactions of Aciphex and Zolpidem - a minute ago